Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'tdf ftc'
tdf ftc published presentations and documents on DocSlides.
Challenging Cases in Antiretroviral Therapy and Panel Discussion
by gagnon
Paul E. Sax, MD. Professor of Medicine. Harvard Me...
Optimizing HIV treatment
by anderson
Professor Francois Venter. Ezintsha, University of...
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
Switching the NRTI Backbone to Tenofovir DF-Emtricitabine
by reese
TOTEM. Switching the NRTI Backbone to Tenofovir DF...
HIV PREVENTION SAMU SUMMARY
by FluffyFace
2018. Objectives . To describe the current situati...
Clinical Management of PrEP
by SportyChick
U. sers. . W. ho. Test Positive for HIV. Jean-Mi...
Michael S. Saag , MD Professor of Medicine
by roxanne
Associate Dean for Global Health. University of Al...
PrEP Case Studies Module 6
by bethany
Summary recommendations. …. Oral PrEP containing...
What’s New & Next in
by badra
HIV Prevention . Mitchell Warren. July 2021. Outli...
Clinical considerations for the
by helene
introduction . of . DTG. Nandita Sugandhi. ICAP at...
Towards ending the AIDS Epidemic: Progress and Evidence
by shoulderheinz
Willard . Tinago. , . PhD. HIV . Molecular Researc...
Clinical M anagement
by natalia-silvester
Clinical M anagement Module 4 (e) Pregnancy a...
2013 Antimicrobial Update
by marina-yarberry
Oklahoma ACP Chapter . October 18, 2013. Michelle...
Comparison of PI vs PI ATV vs ATV/r BMS 089
by phoebe-click
LPV/r mono vs LPV/r ZDV/3TC MONARK. LPV/r QD v...
Module 1: INTRODUCTION TO ORAL
by pamella-moone
PrEP. Version. : December . 2018. Outline of tra...
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
Donna E. Sweet, MD, AAHIVS, MACP
by pasty-toler
Professor of Medicine. The University of Kansas S...
Modifying Therapy in the Treatment-experienced Patient:
by yoshiko-marsland
When should it be done?. Professor of Medicine. U...
Highlights for clinical
by pasty-toler
. practice. HIV. International Congress of Drug ...
The Role of Pre-Exposure Prophylaxis (
by tatyana-admore
PrEP. ) for the Prevention of HIV. Sarah . Kemink...
Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan
by sherrill-nordquist
± . Ritonavir. Carey Hwang. ,. 1. Dirk Schürma...
ADOLESCENT PrEP STUDIES
by min-jolicoeur
. . Shorai. . Mukaka. , . MBchB. ...
Adaptive non-inferiority
by cheryl-pisano
margins under observable non-constancy. Brett Han...
Characteristics and Oral
by lois-ondreau
PrEP. Adherence in the TDF2 Open-Label Extension...
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
Review of Non-Daily PrEP Clinical Research and Experience
by mitsue-stanley
Robert M. Grant, M.D., M.P.H. .. IAS 2017, July 2...
CROI 2015: What’s New in Hepatitis?
by myesha-ticknor
Nina Kim, MD . Associate Professor of Medicine. D...
Treatment-Experienced Patients in Resource-Limited Settings
by pasty-toler
Susan M. Graham . Assistant Professor, Medicine a...
PrEP Training for
by tatyana-admore
Providers in Clinical Settings. 2. Welcome!. Plea...
Comparison of INSTI vs INSTI
by pamella-moone
QDMRK. SPRING-2. ONCEMRK. ONCEMRK. Design. Object...
ID Week 2016: HIV Update
by min-jolicoeur
Robert Harrington, M.D.. ID Week 2016: HIV Update...
Innovative Strategies for the Management
by karlyn-bohler
of HIV Infection. Dual therapies without NRTIs. J...
CROI 2015: HIV Prevention Updates
by pamella-moone
Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...
Switch to ATV/
by cheryl-pisano
r. + RAL. HARNESS Study. ATV/. r. 300/100 mg ....
Load More...